Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect.

Literature DB >> 25146841

Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect.

Bulent Yilmaz¹, Emir Charles Roach, Seyfettin Koklu.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 25146841 DOI： 10.1007/s10620-014-3323-z

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

3 in total

1. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis.

Authors: Gerard Ozorio; Bruce McGarity; Haesung Bak; Andrew S Jordan; Henry Lau; Cathy Marshall
Journal: Med J Aust Date: 2007-11-05 Impact factor: 7.738

2. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.

Authors: Dahlia A Goldfeld; Elizabeth C Verna; Jay Lefkowitch; Arun Swaminath
Journal: Dig Dis Sci Date: 2011-05-20 Impact factor: 3.199

Review 3. Infliximab-related hepatitis: a case study and literature review.

Authors: Francisco Colina; Aída Molero; Begoña Casís; Pilar Martínez-Montiel
Journal: Dig Dis Sci Date: 2013-05-05 Impact factor: 3.199

3 in total

5 in total

Review 1. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Authors: Ersilia M DeFilippis; Sonal Kumar
Journal: Dig Dis Sci Date: 2015-05-22 Impact factor: 3.199

2. Protective Effect of Pogostone on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis via Inhibition of T Helper Cell.

Authors: Jiyan Su; Cailan Li; Xiuting Yu; Guanghua Yang; Jianhua Deng; Ziren Su; Huifang Zeng; Jiannan Chen; Xiaojun Zhang; Xiaoping Lai
Journal: Front Pharmacol Date: 2017-11-17 Impact factor: 5.810

Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect.

1. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis.

2. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.

Review 3. Infliximab-related hepatitis: a case study and literature review.

Review 1. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

2. Protective Effect of Pogostone on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis via Inhibition of T Helper Cell.

Review 3. Secondary causes of inflammatory bowel diseases.

Review 4. Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?

Review 5. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.